Bing Xiu
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Lymphoma Diagnosis and Treatment 12
-
- Ubiquitin and proteasome pathways 3
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- Aibin Liang (18 shared papers)Wenjun Zhang (9 shared papers)Stephen M. Ansell (3 shared papers)Deanna M. Grote (3 shared papers)Anne J. Novak (3 shared papers)Steven C. Ziesmer (3 shared papers)Huazong Zeng (1 shared paper)Yi-Qing Qu (1 shared paper)
- Journals
- Blood (2 papers)Clinical Cancer Research (1 paper)Oncology Reports (1 paper)International Journal of Biological Macromolecules (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Bing Xiu
21 papers receiving 356 citations
Peers
Comparison fields: 5 of 61
- Pathology and Forensic Medicine 128
- Oncology 190
- Drug Discovery 1
- Immunology 117
- Cancer Research 71
Countries citing papers authored by Bing Xiu
This map shows the geographic impact of Bing Xiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xiu more than expected).
Fields of papers citing papers by Bing Xiu
This network shows the impact of papers produced by Bing Xiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xiu. The network helps show where Bing Xiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Xiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 81 | |
| 2 | 2011 | 60 | |
| 3 | 2013 | 58 | |
| 4 | 2017 | 44 | |
| 5 | Circular RNA profile of acute myeloid leukaemia indicates circular RNA annexin A2 as a potential biomarker and therapeutic target for acute myeloid leukaemia. | 2020 | 24 |
| 6 | 2020 | 18 | |
| 7 | Up-regulation of VEGF and its receptor in refractory leukemia cells. | 2015 | 17 |
| 8 | 2012 | 14 | |
| 9 | 2013 | 10 | |
| 10 | 2013 | 5 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2017 | 4 | |
| 14 | 2024 | 3 | |
| 15 | 2024 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2012 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2013 | 1 | |
| 20 | [Study of hypermethylation of SOCS gene in typical myeloproliferative disease]. | 2011 | 1 |
About Bing Xiu
Bing Xiu is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Oncology, Hematology and Genetics, having authored 25 papers that have together received 358 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), CAR-T cell therapy research (5 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Ubiquitin and proteasome pathways (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (128 citations), Oncology (190 citations), Drug Discovery (1 citation), Immunology (117 citations) and Cancer Research (71 citations). Bing Xiu has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Aibin Liang, Wenjun Zhang, Stephen M. Ansell, Deanna M. Grote, Anne J. Novak, Steven C. Ziesmer, Huazong Zeng, Yi-Qing Qu, Anmei Deng and Jason M. Jones. Their work appears in journals such as Blood, Clinical Cancer Research, Oncology Reports, International Journal of Biological Macromolecules and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.